Asm. Diane Papan

This measure would declare August 2023 as Valley Fever Awareness Month.

This measure would designate the month of June 2023 as Healthy Homes Awareness Month.

This measure would recognize July 28 as World Hepatitis Day and would urge all California institutions, nonprofit organizations, health care organizations, businesses, community leaders, and residents to ensure screenings for hepatitis B and C, vaccinations for hepatitis B, and treatment become the standard of care.

This measure would designate October 23, 2023, as Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Awareness Day in the state.

This measure would recognize August 15, 2023, as India's Independence Day and urge all Californians to join in celebrating India's independence.

This measure would proclaim August 2023 as Breastfeeding Awareness Month of 2023 in California. The measure would recognize the unique benefits that breastfeeding provides, as specified, and would affirm that Californians should work to ensure that barriers to initiation and continuation of breastfeeding are removed. The measure would encourage Californians to work together to explore ways to, among other things, improve women's access to breastfeeding support services in medical, social, and employment settings.

This measure would recognize the 50th anniversary of hip hop on August 11, 2023, as a time of celebration, pride, and nostalgia for the citizens of California.

Existing law requires the State Department of Public Health to administer a statewide program for prenatal testing for genetic disorders and birth defects, including, but not limited to, ultrasound, amniocentesis, chorionic villus sampling, and blood testing. Existing law requires the department to expand prenatal screening to include all tests that meet or exceed the current standard of care as recommended by nationally recognized medical or genetic organizations and to establish any rules, regulations, and standards for prenatal diagnostic testing and the allocation of subsidies, as specified. Existing law requires a clinical laboratory performing laboratory tests or examinations classified as moderate or high complexity under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) to obtain a clinical laboratory license from the department. Existing law generally exempts specified clinical laboratories from rules and regulations of the department, including clinical laboratories owned and operated by the United States and certified under CLIA. Under existing regulations, a certificate of accreditation issued by the United States Department of Health and Human Services is considered a state license or registration issued by the department, as specified. Existing law requires a city or county public health laboratory, as specified, to be approved by the department and to comply with the requirements of CLIA. This bill would prohibit the department, by way of rule, regulation, contract, or any other manner, from preventing a laboratory with both a CLIA certificate of accreditation and a current state clinical or public health laboratory license from offering all noninvasive prenatal tests to pregnant persons who have an order from a prenatal care provider, as defined. The bill would also prohibit the department from limiting the number of noninvasive prenatal tests that the laboratory may provide.